Cyclerion Therapeutics, Inc.
CYCN
$3.79
-$0.12-3.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.71M | -5.28M | -3.53M | -2.20M | -1.95M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 322.00K | 385.00K | 441.00K | 468.00K | 125.00K |
| Change in Net Operating Assets | 1.93M | 1.37M | -227.00K | 356.00K | -1.01M |
| Cash from Operations | -4.45M | -3.52M | -3.31M | -1.38M | -2.83M |
| Capital Expenditure | -66.00K | -66.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -66.00K | -66.00K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.90M | 2.90M | 3.45M | 3.20M | 1.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -130.00K | -130.00K | -130.00K | -130.00K |
| Cash from Financing | 2.90M | 2.77M | 3.32M | 3.07M | 1.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.62M | -816.00K | 8.00K | 1.70M | -1.58M |